Champions Oncology (CSBR) Tax Rate (2011 - 2026)

Champions Oncology (CSBR) recorded quarterly Tax Rate of 17.72% in Q1 2026, down 351.05% quarter-over-quarter from 7.06% in Q4 2025, and down 1823.0% on a YoY basis from 1.03% in Q1 2025.

Champions Oncology (CSBR) Tax Rate (2011 - 2026) Analysis & Trends

Champions Oncology's Tax Rate history runs 16 years deep, the most recent figure standing at 17.72% for Q1 2026.

  • In Q1 2026, Tax Rate fell 1823.0% year-over-year to 17.72%; the TTM figure through Jan 2026 stood at 2.29% (up 270.0% YoY), while the FY2025 annual figure was 1.62%, down 206.0% from the prior year.
  • Tax Rate was 17.72% for Q1 2026 at Champions Oncology, down from 7.06% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 42.63% in Q2 2024 to a low of 700.0% in Q4 2022.
  • Historically, Tax Rate has averaged 39.31% across 5 years, with a median of 0.44% in 2024.
  • The sharpest annual moves came in 2022 and 2023: Tax Rate sank 70415 bps in 2022, then soared 69947 bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 700.0% in 2022, then soared by 100 bps to 0.53% in 2023, then soared by 379 bps to 1.49% in 2024, then surged by 374 bps to 7.06% in 2025, then slumped by 351 bps to 17.72% in 2026.
  • The last three Tax Rate figures came in at 17.72% (Q1 2026), 7.06% (Q4 2025), and 3.1% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -57.14%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 5.61%
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -6.79%
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 17.68%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Champions Oncology 82.77 Mn 75.76 Mn 13.89 Mn -17.72%

Historic Data

Download Data
DateValue
Jan 31, 2026 -17.72%
Jan 31, 2026 -17.72%
Oct 31, 2025 7.06%
Oct 31, 2025 7.06%
Jul 31, 2025 -3.10%
Jul 31, 2025 -3.10%
Apr 30, 2025 6.57%
Apr 30, 2025 6.57%
Jan 31, 2025 0.51%
Jan 31, 2025 0.51%
Oct 31, 2024 1.49%
Oct 31, 2024 1.49%
Jul 31, 2024 1.57%
Jul 31, 2024 1.57%
Apr 30, 2024 42.63%
Apr 30, 2024 42.63%
Jan 31, 2024 -0.44%
Jan 31, 2024 -0.44%
Oct 31, 2023 -0.53%
Oct 31, 2023 -0.53%